- Anecortave
drugbox
width=200
IUPAC_name = [2- [(8R,10S,13S,14R,17R)-
17-hydroxy-10,13-dimethyl-3-oxo-
2,6,7,8,12,14,15,16-octahydro-
1H-cyclopenta [a] phenanthren-17-yl] -
2-oxo-ethyl] acetate
CAS_number = 7753-60-8
ATC_prefix=S01
ATC_suffix=XA16
PubChem=111332
DrugBank=?
C=23 | H=30 | O=5
molecular_weight = 386.48
bioavailability = ?
metabolism = ?
elimination_half-life = ?
excretion = ?
pregnancy_category = ?
legal_status = Schedule 4 (Aust)
routes_of_administration =intravitreal depot injectionAnecortave (rINN) (pronEng|ænəˈkɔrteɪv) is a novel
angiogenesis inhibitor used in the treatment of the exudative (wet) form of age-relatedmacular degeneration . Although based on asteroid nucleus, it possesses littleglucocorticoid activity. It will be marketed byAlcon as anecortave acetate for depot suspension under the trade name Retaane.External links
Wikimedia Foundation. 2010.